Okay let me start by saying this, a early surprise approval I would not enjoy since the upside will not be near a approval on the pdufa date. Here is why partly because it is early people won't chase, as they would chase as approval nears.
The short float is big and expiring out before end of month this is a catalyst in itself, this could raise the pps 1.00 to 3.00 on its own.
Today options expire so we can really get a direction in the coming days of what everyone thinks the approval pps will be I'm watching that 1.00 mark on the 27.00 and 28.00 if those increase then that 30.00 price tag on approval seems legit.
Best of luck to all of you as I own shares and 19.00 options for august
Yes, what would you like to know about me?
As you see I am excited about PDUFA as it is less then a month away now.
If you want to know my price predictions its 20.00 pre data
I wish you well.
I don't have ADD I just love watching the companies that make me $$$
Once 40.00 falls the bottom is unknown. So i will take the quick cash
This seems to have a lot of backing and will essentially be the way they become private. Once private that .80 cents on the dollar I proposed to take, I will reinvest in them for a huge run.
When apple says 25 million iRadio users, everyone in pandora will be heading for the exits. Then metrics next week send this to 18 and earnings 12. Geee pump and dump here
LOL ya when they report the most iPhone 5s sales in history of the company, o and 5c is now catching up. Keep dreaming shorty get burned. Apple 700 coming before january. FOOL
Ive argued with him over Arena Pharmas drug if it would get approved. He was saying no way will it ever get approved, however he had no idea what any of the medical or chemistry interactions were about in the drug Belviq. If you look at his article he just states a very bias opinion on Abstral even though its a leader in sales in Europe and is big in the east, and Canada. Adam states they need more money, but gives no real reason dosn't mention cash flow burn rate or anything just they need more cash. His reputation has fallen a lot since I started attacking him on the stock twits boards, probably why he stopped posting. Either way hes a fraud this is very cheap should be before any sales 2.50 greatly under valued, as the analyst agree.
Lol Rxii is a great company its brand new needed money why it split its been upticked from otc and now will soon be on nyse. Had great P1 scare reduction 38-50% reduction on double blinded results. The drug works now they just need to rinse and repeat the results. Rxii long term will be about 9-10 dollars after P3 results. Your clueless.
Yup i bought 10k at 1.30 and then 10k at 1.70 and i see this going to 8 in about 9 months. Good call glad i doubled down.
Earnings will shed light on how good the company is, and 1.53 a pharma company with no money sits around this price. This should be around 5-10 dollars. Should get nice pop on earnings.
Longs win .195 box leaving .40 coming break out on chart will lead with analyst upgrades to .60-.70
looks like red was right it was going to be positive :)
GL biggest positive on the results minimal side effects. Huge plus